Literature DB >> 17506475

Association between vitamin-D receptor gene FokI polymorphism and Graves' disease among Taiwanese Chinese.

Rong-Hsing Chen1, Chwen-Tzuei Chang, Huey-Yi Chen, Wen-Chi Chen, Chang-Hai Tsai, Fuu-Jen Tsai.   

Abstract

1,25(OH)(2)D(3), exerting its biological effects through the vitamin-D receptor (VDR), plays a role in the modulation of the human immune system. The aim of this study was to test for the presence of an association between VDR gene polymorphism and the susceptibility to Graves' disease (GD) for Taiwanese Chinese. Using a polymerase chain reaction (PCR)-based restriction analysis, we screened the VDR exon 2 start codon T/C (VDR-FokI) polymorphism to determine the genotypes for 88 GD patients and 90 normal controls. From the genotype analysis, GD patients featured a greater proportion of the CC genotype (44.3%) and a smaller proportion of the TT genotype (12.5%) than was the case for normal controls (CC: 23.3% and TT: 28.9%; chi-squared test, P=0.003). The odds ratios (ORs) for the risk of the CC genotype's appearance compared with the corresponding values for the TT and TC genotypes, for the GD patient group, were, 4.39 (95% confidence interval [CI]: 1.82-10.61) and 2.10 (95% CI: 1.06-4.18), respectively. With respect to the allelic analysis, we observed significantly increased C-allele (65.9%) and decreased T-allele (34.1%) frequencies among GD patients compared to normal controls (C: 47.2% and T: 52.8%; chi-squared test, P=0.002). The OR for the risk of appearance of the C allele in the GD-patient group was 1.93 (95% CI: 1.27-2.95). In conclusion, the VDR-FokI T/C polymorphism might be able to be used as a genetic marker to predict the likelihood of GD development. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17506475      PMCID: PMC6649158          DOI: 10.1002/jcla.20163

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  27 in total

1.  Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease.

Authors:  T Kawakami-Tani; E Fukawa; H Tanaka; Y Abe; I Makino
Journal:  Metabolism       Date:  1997-10       Impact factor: 8.694

Review 2.  The role of IL-10 in crossregulation of TH1 and TH2 responses.

Authors:  T R Mosmann; K W Moore
Journal:  Immunol Today       Date:  1991-03

3.  The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women.

Authors:  S S Harris; T R Eccleshall; C Gross; B Dawson-Hughes; D Feldman
Journal:  J Bone Miner Res       Date:  1997-07       Impact factor: 6.741

4.  Revised nomenclature for tests of thyroid hormones and thyroid-related proteins in serum.

Authors:  P R Larsen; N M Alexander; I J Chopra; I D Hay; J M Hershman; M M Kaplan; C N Mariash; J T Nicoloff; J H Oppenheimer; D H Solomon
Journal:  J Clin Endocrinol Metab       Date:  1987-05       Impact factor: 5.958

5.  The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women.

Authors:  C Gross; T R Eccleshall; P J Malloy; M L Villa; R Marcus; D Feldman
Journal:  J Bone Miner Res       Date:  1996-12       Impact factor: 6.741

6.  Cyclooxygenase-dependent thyroid cell proliferation induced by immunoglobulins from patients with Graves' disease.

Authors:  R Di Paola; C Menzaghi; V De Filippis; D Corda; A Di Cerbo
Journal:  J Clin Endocrinol Metab       Date:  1997-02       Impact factor: 5.958

7.  HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective.

Authors:  Q Y Chen; W Huang; J X She; F Baxter; R Volpe; N K Maclaren
Journal:  J Clin Endocrinol Metab       Date:  1999-09       Impact factor: 5.958

8.  Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Differential effects on CD45RA+ and CD45R0+ cells.

Authors:  K Müller; K Bendtzen
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

Review 9.  Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions.

Authors:  J M Lemire; D C Archer; L Beck; H L Spiegelberg
Journal:  J Nutr       Date:  1995-06       Impact factor: 4.798

Review 10.  Immunomodulatory actions of 1,25-dihydroxyvitamin D3.

Authors:  J M Lemire
Journal:  J Steroid Biochem Mol Biol       Date:  1995-06       Impact factor: 4.292

View more
  4 in total

1.  The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases.

Authors:  N Inoue; M Watanabe; N Ishido; Y Katsumata; T Kagawa; Y Hidaka; Y Iwatani
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

2.  Vitamin D in Graves Disease: Levels, Correlation with Laboratory and Clinical Parameters, and Genetics.

Authors:  Tereza Planck; Bushra Shahida; Johan Malm; Jonas Manjer
Journal:  Eur Thyroid J       Date:  2017-11-21

3.  Association between TSHR gene polymorphism and the risk of Graves' disease: a meta-analysis.

Authors:  Wei Qian; Kuanfeng Xu; Wenting Jia; Ling Lan; Xuqin Zheng; Xueyang Yang; Dai Cui
Journal:  J Biomed Res       Date:  2015-09-03

4.  Meta-Analysis of the Association between Vitamin D Receptor Polymorphisms and the Risk of Autoimmune Thyroid Disease.

Authors:  Xue-Ren Gao; Yong-Guo Yu
Journal:  Int J Endocrinol       Date:  2018-03-22       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.